TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. 2009 LONG-TERM INCENTIVE PLAN Stock Option Award Agreement

EX-10.7.2 3 a2194662zex-10_72.htm EXHIBIT 10.7.2

Exhibit 10.7.2

 

TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.

2009 LONG-TERM INCENTIVE PLAN

 


 

Stock Option Award Agreement

 


 

You are hereby awarded stock options (the “Options”) to purchase Shares of Talecris Biotherapeutics Holdings Corp. (the “Company”), subject to the terms and conditions set forth in this Stock Option Award Agreement (the “Award Agreement”) and in the Talecris Biotherapeutics Holdings Corp. 2009 Long-Term Incentive Plan (the “Plan”).  A copy of the Plan is attached as Exhibit A, and a prospectus describing the Plan’s material terms is attached or will be delivered to you separately.  Terms below that begin with capital letters have the special meaning set forth in the Plan or in this Award Agreement.

 

This Award is conditioned on your execution of this Award Agreement within 20 (twenty) days after the Grant Date specified in Section 1 below.  By executing this Award Agreement, you will be irrevocably agreeing that all of your rights under this Award will be determined solely and exclusively by reference to the terms and conditions of the Plan, subject to the provisions set forth below.  As a result, you should not execute this Award Agreement until you have carefully considered the terms and conditions of the Plan and this Award, plus the information disclosed within the attached Plan prospectus, and (ii) consulted with your personal legal and tax advisors about all of these documents.

 

1.             Specific Terms.  Your Options have the following terms:

 

Name of Participant

 

 

 

 

 

Type of Option:

 

¨ Incentive Stock Option (ISO)

 

ý Non-Incentive Stock Option (non-ISO)

 

 

 

Grant Date:

 

 

 

 

 

Expiration Date:

 

10 years after Grant Date, at 5:00 p.m. (E.D.T. or E.S.T., as applicable) on the Expiration Date.

 

 

 

Exercise Price:

 

U.S. $      .       per Share

 

 

 

Number of Shares Subject to Award:

 

 

 

 

 

Vesting:

 

Your Award will vest, and thereby become exercisable with respect to the number of Shares covered by this Award, at the rate of one-third (1/3) on each of the three annual vesting dates beginning April 1, 2011, provided that either (i) your Continuous Service has not ended before the particular vesting date or (ii) if your Continuous Service has ended before a particular vesting date, you qualify for post-retirement vesting as provided in Section 5 below (all subject to any employment agreement between you and the Company).

 

 

 

Accelerated Vesting

 

You will become 100% vested in this Award if your Continuous Service ends due to your death or your Disability as defined in the Plan.

 



 

Lifetime Transfer:

 

x Allowed for Non-ISOs pursuant to Section 12(b) of the Plan.

 

o Not allowed.

 

 

 

Recapture and Recoupment

 

x Section 25 of the Plan shall apply re Termination, Rescission, and Recapture of this Award.

 

o Section 26 shall apply re Recoupment of this Award.

 

2.             Manner of Exercise.  The Options shall be exercised in the manner set forth in the Plan, using the exercise form attached hereto as Exhibit B.  The amount of Shares for which the Options may be exercised is cumulative; that is, if you fail to exercise the Options for all of the Shares vested under the Options during any period set forth above, then any Shares subject to the Options that are not exercised during such period may be exercised during any subsequent period, until the expiration or termination of the Options pursuant to Sections 1 and 4 of this Award Agreement and the terms of the Plan.  Fractional Shares may not be purchased.

 

3.             Special ISO Provisions.  If designated as an ISO, this Option shall be treated as an ISO to the extent allowable under Section 422 of the Code, and shall otherwise be treated as a Non-ISO.  If you sell or otherwise dispose of Shares acquired upon the exercise of an ISO within 1 year from the date such Shares were acquired or 2 years from the Grant Date, you agree to deliver a written report to the Company within 10 days following the sale or other disposition of such Shares detailing the net proceeds of such sale or disposition.

 

4.             Termination of Continuous Service.  Subject to the terms of any employment agreement between you and the Company (and/or any Affiliate) that is in effect when your Continuous Service terminates and Section 5 below, this Award shall be canceled and become automatically null and void immediately after termination of your Continuous Service for any reason, but only to the extent you have not become vested, pursuant to the terms of Section 1 above, on or before your Continuous Service ends.

 

5.             Post-Retirement Vesting.   In the event that (i) your Continuous Service has terminated prior to a vesting date by reason of your Retirement as defined in the Plan and (ii) you have not become “Otherwise Employed,” then this Option will continue to vest in the same manner as if you had remained in Continuous Service.  In the event that you become Otherwise Employed or fail to provide the Committee with written notice within 10 days after you have accepted an employment or consulting position with an employer unrelated to the Company, then this Option shall be canceled and become automatically null and void, but only to the extent you have not become vested, pursuant to terms of Section 1 above or this Section, on or before you became Otherwise Employed.  For purposes of this Award, “Otherwise Employed” means that following termination of your Continuous Service you have accepted an employment or consulting position with an employer unrelated to the Company; provided that you shall not be considered “Otherwise Employed” if you have presented the Committee with verifiable evidence establishing that your new position may not reasonably be expected to result in base pay and bonus over a period of a calendar year greater than 50 percent of the average of your base pay and bonus for your last two calendar years of employment.  In the event of a dispute regarding whether you have become Otherwise Employed, the Committee shall make a final determination as provided in Section 4(d) of the Plan.  For the avoidance of confusion, investment income or income incurred by reason of vesting of

 

2



 

Awards or exercise of Options awarded by the Company, shall not be considered income for purposes of determining whether you have become Otherwise Employed.

 

6.             Designation of Beneficiary.  Notwithstanding anything to the contrary contained herein or in the Plan, following the execution of this Award Agreement, you may expressly designate a death beneficiary (the “Beneficiary”) to your interest if any, in this Award and any underlying Shares.  You shall designate the Beneficiary by completing and executing a designation of beneficiary agreement substantially in the form attached hereto as Exhibit C (the “Designation of Death Beneficiary”) and delivering an executed copy of the Designation of Beneficiary to the Company.  To the extent you do not duly designate a beneficiary who survives you, your estate will automatically be your beneficiary.

 

7.             Restrictions on Transfer of Award. Your rights under this Award Agreement may not be sold, pledged, or otherwise transferred without the prior written consent of the Committee, except as hereinafter provided.  If Section 1 allows you to make a transfer of Non-ISOs subject to this Award, you may transfer the Non-ISOs as follows:  —

 

(i)                           by instrument to an inter vivos or testamentary trust (or other entity) in which each beneficiary is a Permitted Transferee, as defined in subsection (ii) of this Section, or

 

(ii)                        by gift to charitable institutions or by gift or transfer for consideration to any of the following relatives of yours: any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, domestic partner, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and shall include adoptive relationships (each a “Permitted Transferee”).

 

Any Permitted Transferee of your rights shall succeed and be subject to all of the terms of this Award Agreement and the Plan.

 

8.             Taxes.  Except to the extent otherwise specifically provided in an employment or consulting agreement between you and the Company, by signing this Award Agreement, you acknowledge that you shall be solely responsible for the satisfaction of any applicable taxes that may arise pursuant to this Award (including taxes arising under Code Section 409A (regarding deferred compensation) or 4999 (regarding golden parachute excise taxes), and that neither the Company nor the Administrator shall have any obligation whatsoever to pay such taxes or to otherwise indemnify or hold you harmless from any or all of such taxes.  The Committee shall have the sole discretion to interpret the requirements of the Code, including Section 409A, for purposes of the Plan and this Award Agreement.

 

9.             Not a Contract of Employment.  By executing this Award Agreement you acknowledge and agree that (i) nothing in this Award Agreement or the Plan confers on you any right to continue an employment, service or consulting relationship with the Company, nor shall it affect in any way your right or the Company’s right to terminate your employment, service, or consulting relationship at any time, with or without Cause; and (ii) the Company would not have granted this Award to you but for these acknowledgements and agreements.

 

3



 

10.          Long-term Consideration for Award.  If Section 1 above provides for the application of Plan Section 25 to this Award, then the terms and conditions set forth in your existing Talecris Intellectual Property Agreement or such other employment agreement that includes terms intended to protect Talecris’ business interests, as amended from time-to-time in accordance with its terms, (the “Business Protection Agreement”) are hereby incorporated by reference and made an integral part of this Award Agreement.  An invalidation or incompletion of all or part of the Business Protection Agreement, or your commencement of litigation to invalidate, modify, or alter the terms and conditions set forth your Business Protection Agreement, shall cause this Award to become null, void, and unenforceable.

 

11.          Investment Purposes. By executing this Award Agreement, you represent and warrant that any Shares issued to you pursuant to your Options will be held for investment for your own account, and not with a view to, for resale in connection with, or with an intent in participating directly or indirectly in, any distribution of such Shares within the meaning of the Securities Act of 1933, as amended.

 

12.          Securities Law Restrictions.  Regardless of whether the offering and sale of Options or Shares under the Plan have been registered under the Securities Act of 1933, as amended (the “Securities Act”), or have been registered or qualified under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such Shares (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Securities Act or the securities laws of any state or any other law or to enforce the intent of this Award.

 

13.          Headings.  Section and other headings contained in this Award Agreement are for reference purposes only and are not intended to describe, interpret, define or limit the scope or intent of this Award Agreement or any provision hereof.

 

14.          Severability.  Every provision of this Award Agreement and of the Plan is intended to be severable.  If any term hereof is illegal or invalid for any reason, such illegality or invalidity shall not affect the validity or legality of the remaining terms of this Award Agreement.

 

15.          Counterparts.  This Award Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

 

16.          Notices.  Any notice or communication required or permitted by any provision of this Award Agreement to be given to you shall be in writing and shall be delivered electronically, personally, or sent by mail addressed to you at the last address that the Company had for you on its records.  Each party may, from time to time, by notice to the other party hereto, specify a new address for delivery of notices relating to this Award Agreement.  Any such notice shall be deemed to be given as of the date such notice is personally or electronically delivered or properly mailed.

 

17.          Binding Effect.  Except as otherwise provided in this Award Agreement or in the Plan, every covenant, term, and provision of this Award Agreement shall be binding upon and inure to

 

4



 

the benefit of the parties hereto and their respective heirs, legatees, legal representatives, successors, transferees, and assigns.

 

18.          Modifications.  This Award Agreement may be modified or amended at any time, in accordance with Section 15 of the Plan and provided that you must consent in writing to any modification that adversely and materially affects any rights or obligations under this Award Agreement.

 

19.          Plan Governs.  By signing this Award Agreement, you acknowledge that you have received a copy of the Plan and that your Award Agreement is subject to all the provisions contained in the Plan, the provisions of which are made a part of this Award Agreement and your Award is subject to all interpretations, amendments, rules and regulations which from time to time may be promulgated and adopted pursuant to the Plan.  In the event of a conflict between the provisions of this Award Agreement and those of the Plan, the provisions of the Plan shall control.

 

20.          Governing Law.  The laws of the State of Delaware shall govern the validity of this Award Agreement, the construction of its terms, and the interpretation of the rights and duties of the parties hereto.

 

BY YOUR SIGNATURE BELOW, along with the signature of the Company’s representative, you and the Company agree that this Award is made under and governed by the terms and conditions of this Award Agreement and the Plan.

 

 

 

TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.

 

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

 

 

PARTICIPANT

 

 

 

The undersigned Participant hereby accepts the terms of this Award Agreement and the Plan.

 

 

 

By:

 

 

 

 

 

Name of Participant:

 

 

5



 

Exhibit A

 

Talecris Biotherapeutics Holdings Corp.

2009 Long-Term Incentive Plan

 


 

Plan Document

 


 



 

Exhibit B

 

Talecris Biotherapeutics Holdings Corp.

2009 Long-Term Incentive Plan

 


 

Form of Exercise of Stock Option Award Agreement

 


 

Talecris Biotherapeutics Holdings Corp.

 

Attention:

 

 

Dear Sir or Madam:

 

The undersigned elects to exercise his/her Incentive Stock Options to purchase            shares of Common Stock of Talecris Biotherapeutics Holdings Corp. (the “Company”) under and pursuant to a Stock Option Agreement dated as of                             .

 

1.             o Delivered herewith is a certified or bank cashier’s or teller’s check and/or shares of Common Stock held by the undersigned for at least six months, valued at the closing sale price of the stock on the business day prior to the date of exercise, as follows:

 

$

 

in cash or check

$

 

in the form of          shares of Common Stock,

 

 

valued at $                      per share

 

 

 

$

Total

 

 

 

2.             o Delivered herewith are irrevocable instructions to a broker approved by the Company to deliver promptly to the Company the amount of sale or loan proceeds to pay the exercise price(1).

 

If method 1 is chosen, the name or names to be on the stock certificate or certificates and the address and Social Security Number of such person(s) is as follows:

 

Name:

 

 

 

Address:

 

 

 

Social Security Number

 

 

 

 

Very truly yours,

 

 

 

 

 

 

Date

Optionee

 


(1) Future feature available when implemented.

 



 

Exhibit C

 

Talecris Biotherapeutics Holdings Corp.

2009 Long-Term Incentive Plan

 


 

Designation of Death Beneficiary

 


 

In connection with the Awards designated below that I have received pursuant to the Talecris Biotherapeutics Holdings Corp. 2009 Long-Term Incentive Plan (the “Plan”), I hereby designate the person specified below as the beneficiary upon my death of my interest in such Awards.  This designation shall remain in effect until revoked in writing by me.

 

Name of Beneficiary:

 

Address:

 

 

 

Social Security No.:

 

This beneficiary designation relates to any and all of my rights under the following Award or Awards:

 

o                                    any Award that I have received or ever receive under the Plan.

 

o                                    the Stock Option Award that I received pursuant to an award agreement dated                        ,          between myself and the Company.

 

I understand that this designation operates to entitle the above named beneficiary, in the event of my death, to any and all of my rights under the Award(s) designated above from the date this form is delivered to the Company until such date as this designation is revoked in writing by me, including by delivery to the Company of a written designation of beneficiary executed by me on a later date.

 

 

Date:

 

 

 

 

 

By:

 

 

 

Name of Participant

 

Sworn to before me this

        day of                         , 20  

 

Notary Public

County of

State of